Flputnam Investment Management Co. Buys Shares of 1,502 iShares Biotechnology ETF (NASDAQ:IBB)

Flputnam Investment Management Co. purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 1,502 shares of the financial services provider’s stock, valued at approximately $204,000.

Several other institutional investors have also modified their holdings of IBB. Moneta Group Investment Advisors LLC boosted its stake in iShares Biotechnology ETF by 131,598.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 4,469,845 shares of the financial services provider’s stock worth $586,846,000 after purchasing an additional 4,466,451 shares during the period. JPMorgan Chase & Co. boosted its position in shares of iShares Biotechnology ETF by 159.9% during the first quarter. JPMorgan Chase & Co. now owns 1,966,359 shares of the financial services provider’s stock worth $253,975,000 after buying an additional 1,209,700 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of iShares Biotechnology ETF by 49.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after buying an additional 521,820 shares during the period. Jane Street Group LLC grew its holdings in shares of iShares Biotechnology ETF by 5.4% during the fourth quarter. Jane Street Group LLC now owns 1,002,554 shares of the financial services provider’s stock worth $131,625,000 after buying an additional 50,999 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at approximately $76,425,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.0 %

NASDAQ:IBB opened at $124.64 on Friday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16. The business has a 50 day moving average price of $135.29 and a two-hundred day moving average price of $129.51.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.40%. The ex-dividend date of this dividend was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.